Targeted sequencing of paired tumour/blood of 78 Ta stage bladder cancer patients
Ontology highlight
ABSTRACT: In continuation of our whole-exome and targeted sequencing study on non-muscle-invasive bladder cancer, we carried out this targeted paired tumour/blood sequencing study including 78 Ta stage bladder cancer patients. Agilent’s SureDesign tool was used to design a 1.133 Mb SureSelect custom capture for all coding exons of the 140 selected candidate genes.
PROVIDER: EGAS00001005766 | EGA |
REPOSITORIES: EGA
ACCESS DATA